Surgical Treatment of Liver Metastases in Esophageal Cancer

Liver metastases are a significant factor affecting the prognosis and treatment outcomes of patients with esophageal cancer. The incidence of liver metastasis in esophageal cancer ranges from 20 to 50%. The management of esophageal cancer patients with liver metastases requires a multidisciplinary approach to optimize treatment options and increase the number of treated patients. Diagnostic methods for liver metastases in esophageal cancer include imaging methods such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. Biopsy can also be performed to confirm the presence of cancer cells in the liver. Surgical intervention for liver metastases in esophageal cancer is rarely performed due to the advanced stage of the disease and limited surgical options. The selection of cases suitable for surgical intervention depends on factors such as the number, size, and location of liver metastases. Alternative treatment options include chemotherapy, radiotherapy, and local regional treatments. Recent studies have reported that patients with a low liver tumor burden may have a favorable prognosis with liver resection after chemotherapy. However, large-scale randomized studies comparing surgical and palliative treatments are lacking. Ablative therapies such as radiofrequency ablation (RFA) have shown promising results in treating liver tumors that cannot be surgically removed. An aggressive, multidisciplinary approach is necessary to optimize the management of liver metastatic esophageal cancer, and further research is needed to improve patient selection and treatment protocols.